INOVIO Announces Online Preprint Publication of Homologous Boosting Data for its COVID-19 DNA Vaccine Candidate, INO-4800

/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from...

Related Keywords

China ,Mexico ,Colombia ,Philippines ,South Korea ,Brazil ,Ben Matone ,Jeff Richardson ,Kaneka Eurogentec ,J Joseph Kim ,Walter Reed Army Institute Of Research ,National Cancer Institute ,National Institute Of Allergy ,Plumbline Life Sciences ,Melinda Gates Foundation ,Coalition For Epidemic Preparedness Innovations ,Astrazeneca ,Defense Consortium ,Parker Institute For Cancer Immunotherapy ,International Vaccine Institute ,Health Sciences ,National Institutes Of Health ,Nuclear Defense Department Of ,Apollobio Corporation ,Vaccines Trial Network ,University Of Pennsylvania ,Wistar Institute ,Durable Immune Responses Capable ,Being Boosted ,Label Trial ,Advaccine Biopharmaceuticals ,Epidemic Preparedness Innovations ,Defense Advanced Research Projects ,Joint Program Executive Office ,Trial Network ,National Institutes ,National Institute ,Infectious Diseases ,Ology Bioservices ,Parker Institute ,Richter Helm Biologics ,Thermo Fisher Scientific ,Walter Reed Army Institute ,Inovio Pharmaceuticals ,Nc ,